ANI Pharmaceuticals (ANIP) News Today $62.56 +0.44 (+0.71%) Closing price 06/13/2025 04:00 PM EasternExtended Trading$62.47 -0.09 (-0.14%) As of 06/13/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ANIP Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period ANI Pharmaceuticals Announces Presentation of New Preclinical DataJune 12 at 7:00 AM | globenewswire.comWedge Capital Management L L P NC Lowers Stake in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)Wedge Capital Management L L P NC lowered its position in shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) by 25.0% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 24,168 shares of thJune 11 at 4:37 AM | marketbeat.comGAMMA Investing LLC Purchases 94,464 Shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)GAMMA Investing LLC increased its stake in shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) by 17,558.4% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 95,002 shares of the specialty pharJune 10, 2025 | marketbeat.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Purchases 13,948 Shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its stake in shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) by 41.1% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 47,899June 7, 2025 | marketbeat.comANIP Q1 CY2025 Earnings Call: Generics, Rare Disease Drive Growth; Retina Headwinds NotedJune 6, 2025 | msn.comANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Shares Sold by Nuveen Asset Management LLCNuveen Asset Management LLC lowered its position in shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) by 72.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 49,643 shares of the specialty pharmaceutical company's stJune 3, 2025 | marketbeat.comKings Path Partners LLC Cuts Stake in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)Kings Path Partners LLC lessened its stake in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) by 38.6% during the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 11,913 shares of the specialty pharmaceutical company's stock after selling 7,May 31, 2025 | marketbeat.comBank of America Corp DE Raises Holdings in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)Bank of America Corp DE lifted its stake in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) by 45.1% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 95,160 shares of the specialty pharmaceutical company's stock aMay 29, 2025 | marketbeat.comANI Pharmaceuticals to Present at the 2025 Jefferies Global Healthcare ConferenceMay 27, 2025 | globenewswire.comANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Receives Average Rating of "Buy" from AnalystsShares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Get Free Report) have been assigned an average rating of "Buy" from the nine brokerages that are covering the firm, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold rating, seven have assigned a buy ratingMay 27, 2025 | marketbeat.com3 Reasons to Avoid ANIP and 1 Stock to Buy InsteadMay 26, 2025 | finance.yahoo.comGeneric Pharmaceuticals Stocks Q1 In Review: Amphastar Pharmaceuticals (NASDAQ:AMPH) Vs PeersMay 23, 2025 | msn.comANI Pharmaceuticals Announces Initiation of Phase 4 Clinical Trial of Purified Cortrophin® Gel for the Treatment of Acute Gout FlaresMay 22, 2025 | finance.yahoo.comANI Pharmaceuticals Announces Initiation of Phase 4 Clinical Trial of Purified Cortrophin® Gel for the Treatment of Acute Gout FlaresMay 22, 2025 | globenewswire.comSoleus Capital Management L.P. Has $11.35 Million Stock Position in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)Soleus Capital Management L.P. lowered its stake in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) by 23.7% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 205,294 shares of the specialty pharmaMay 21, 2025 | marketbeat.comStonepine Capital Management LLC Makes New Investment in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)Stonepine Capital Management LLC bought a new position in shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 20,400 shares of the specialty pharmaceuMay 20, 2025 | marketbeat.comTang Capital Management LLC Lowers Holdings in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)Tang Capital Management LLC decreased its position in shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) by 29.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 317,500 shares of the specialty pharmacMay 20, 2025 | marketbeat.comAmeriprise Financial Inc. Raises Holdings in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)Ameriprise Financial Inc. increased its position in shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) by 14.6% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 271,805 shares of the specialty pharmaceutical company's stock aftMay 20, 2025 | marketbeat.comMillennium Management LLC Has $55.44 Million Stock Holdings in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)Millennium Management LLC raised its holdings in shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) by 89.3% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,002,849 shares of the specialty pharmaceutical coMay 19, 2025 | marketbeat.com6,358 Shares in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Acquired by Graham Capital Management L.P.Graham Capital Management L.P. bought a new position in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 6,358 shares of the specialty pharmaceutical company's stock, valMay 19, 2025 | marketbeat.comNorthern Trust Corp Raises Holdings in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)Northern Trust Corp raised its holdings in shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) by 9.0% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 204,345 shares of the specialty pharmaceutical coMay 19, 2025 | marketbeat.comANI Pharmaceuticals, Inc. (NASDAQ:ANIP) SVP Ori Gutwerg Sells 881 SharesMay 17, 2025 | insidertrades.comD. E. Shaw & Co. Inc. Boosts Stake in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)D. E. Shaw & Co. Inc. boosted its holdings in shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) by 80.7% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 196,319 shares of the specialty pharmaceutical compMay 17, 2025 | marketbeat.comANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Insider Sells $241,800.00 in StockMay 16, 2025 | insidertrades.com38,488 Shares in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Acquired by Balyasny Asset Management L.P.Balyasny Asset Management L.P. bought a new position in shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 38,488 shares of the specialty pharmaceutical comMay 15, 2025 | marketbeat.comComerica Bank Sells 8,099 Shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)Comerica Bank lowered its position in shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) by 30.1% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 18,830 shares of the specialty pharmaceuticalMay 15, 2025 | marketbeat.comANI Pharmaceuticals (NASDAQ:ANIP) Earns "Buy" Rating from GuggenheimGuggenheim reiterated a "buy" rating and issued a $86.00 price target on shares of ANI Pharmaceuticals in a research report on Monday.May 14, 2025 | marketbeat.comANI Pharmaceuticals to Participate at the H.C. Wainwright 3rd Annual BioConnect Conference at NASDAQMay 12, 2025 | globenewswire.comTower Research Capital LLC TRC Lowers Stock Holdings in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)Tower Research Capital LLC TRC lessened its stake in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) by 74.7% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,547 shares of the specialty pharmaceutical company's stMay 12, 2025 | marketbeat.comANI Pharmaceuticals (NASDAQ:ANIP) Sets New 52-Week High Following Strong EarningsANI Pharmaceuticals (NASDAQ:ANIP) Reaches New 12-Month High Following Earnings BeatMay 12, 2025 | marketbeat.comANI Pharmaceuticals (NASDAQ:ANIP) Issues FY 2025 Earnings GuidanceANI Pharmaceuticals (NASDAQ:ANIP) updated its FY 2025 earnings guidance. The company provided EPS guidance of 6.270-6.620 for the period, compared to the consensus estimate of 6.340. The company also issued revenue guidance of $768.0 millionillion-$793.0 millionillion, compared to the consensus estimate of $769.6 millionillion.May 11, 2025 | marketbeat.comBridgefront Capital LLC Makes New Investment in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)Bridgefront Capital LLC purchased a new stake in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 3,692 shares of the specialty pharmaceutical companMay 11, 2025 | marketbeat.comANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Q1 2025 Earnings Call TranscriptMay 10, 2025 | msn.comAn Overview of ANI Pharmaceuticals's EarningsMay 9, 2025 | benzinga.comANI Pharma Reports Upbeat Q1 Earnings, Revises Full-Year Outlook: Retail’s PleasedMay 9, 2025 | msn.comANI Pharmaceuticals (NASDAQ:ANIP) Reports Strong Q1, Full-Year Outlook Slightly Exceeds ExpectationsMay 9, 2025 | finance.yahoo.comANI Pharmaceuticals, Inc. (ANIP) Q1 2025 Earnings Call TranscriptMay 9, 2025 | seekingalpha.comDeep Track Capital LP Raises Stake in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)Deep Track Capital LP boosted its holdings in shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) by 28.6% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 649,042 shares of the specialty pharmaceutical company's stocMay 9, 2025 | marketbeat.comANI Pharmaceuticals Reports Record First Quarter 2025 Financial Results and Raises 2025 GuidanceMay 9, 2025 | globenewswire.comEarnings To Watch: ANI Pharmaceuticals (ANIP) Reports Q1 Results TomorrowMay 8, 2025 | finance.yahoo.comState of Tennessee Department of Treasury Sells 4,414 Shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)State of Tennessee Department of Treasury lowered its position in shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) by 54.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 3,730 shares of the specialty phaMay 8, 2025 | marketbeat.comFirst Trust Advisors LP Has $1.80 Million Stock Position in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)First Trust Advisors LP cut its stake in shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) by 13.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 32,531 shares of the specialty pharmaceuMay 8, 2025 | marketbeat.comFreestone Grove Partners LP Takes $259,000 Position in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)Freestone Grove Partners LP acquired a new position in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 4,679 shares of the specialty pharmaceutical company's stock, valued at apMay 7, 2025 | marketbeat.comDimensional Fund Advisors LP Raises Stock Holdings in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)Dimensional Fund Advisors LP raised its holdings in shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) by 4.6% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 685,730 shares of thMay 7, 2025 | marketbeat.comANI Pharmaceuticals: A Short-Term Buying OpportunityMay 6, 2025 | seekingalpha.comANI Pharmaceuticals (NASDAQ:ANIP) Hits New 52-Week High - What's Next?ANI Pharmaceuticals (NASDAQ:ANIP) Sets New 12-Month High - Should You Buy?May 5, 2025 | marketbeat.comANI Pharmaceuticals Announces Presentation of Preclinical Data on the Use of Purified Cortrophin® Gel in an Experimental Autoimmune Uveitis (EAU) Mouse ModelMay 5, 2025 | globenewswire.comAquatic Capital Management LLC Purchases 4,040 Shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)Aquatic Capital Management LLC lifted its position in shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) by 149.6% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 6,740 shares of the speciaMay 5, 2025 | marketbeat.comANI Pharmaceuticals (ANIP) Projected to Post Earnings on FridayANI Pharmaceuticals (NASDAQ:ANIP) will be releasing its Q1 2025 earnings before the market opens on Friday, May 9. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-9-ani-pharmaceuticals-inc-stock/)May 4, 2025 | marketbeat.comANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Given Consensus Recommendation of "Buy" by BrokeragesANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Get Free Report) has been given a consensus rating of "Buy" by the nine research firms that are presently covering the company, Marketbeat reports. One analyst has rated the stock with a hold rating, seven have assigned a buy rating and one has given a stMay 3, 2025 | marketbeat.com Get ANI Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ANIP and its competitors with MarketBeat's FREE daily newsletter. Email Address ANIP Media Mentions By Week ANIP Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ANIP News Sentiment▼1.320.88▲Average Medical News Sentiment ANIP News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ANIP Articles This Week▼56▲ANIP Articles Average Week Get ANI Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ANIP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Nuvalent News Axsome Therapeutics News ADMA Biologics News Vaxcyte News Akero Therapeutics News Rhythm Pharmaceuticals News Zai Lab News PTC Therapeutics News Cytokinetics News Avidity Biosciences News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ANIP) was last updated on 6/14/2025 by MarketBeat.com Staff From Our PartnersThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s worst nightmareThe President’s tour of the Middle East… the deal for Ukraine’s mineral rights… Elon’s strange time in Washing...Porter & Company | SponsoredGet in stocks now - and get out on this dateGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | Sponsored[First Look] Get in before potential 10X AI announcementsGo for 10X gains from the next big AI announcement — starting as soon as 7 days from now Former floor trade...Masters in Trading | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ANI Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ANI Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ANIP Stock Free ANIP Stock Alerts